MILLENNIUM MANAGEMENT LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$197,084
-1.1%
102,648
-25.9%
0.00%
Q2 2023$199,374
+71876.2%
138,454
+5.1%
0.00%
Q1 2023$277
-6.1%
131,773
-49.5%
0.00%
Q4 2022$295
-99.9%
260,906
+7.8%
0.00%
Q3 2022$394,000
+16.2%
241,947
-6.4%
0.00%
Q2 2022$339,000
-37.7%
258,523
-23.5%
0.00%
Q1 2022$544,000
-35.2%
337,953
-16.7%
0.00%
Q4 2021$840,000
-38.2%
405,601
+15.8%
0.00%
-100.0%
Q3 2021$1,359,000
-25.3%
350,336
-38.4%
0.00%0.0%
Q2 2021$1,820,000
+4818.9%
568,690
+5496.8%
0.00%
Q3 2019$37,000
-26.0%
10,161
-14.9%
0.00%
Q2 2019$50,000
-97.3%
11,945
-96.7%
0.00%
-100.0%
Q1 2019$1,857,000
+174.7%
363,472
+223.4%
0.00%
+200.0%
Q3 2018$676,000
+16.2%
112,399
+22.9%
0.00%0.0%
Q2 2018$582,000
+28.2%
91,432
-4.5%
0.00%0.0%
Q1 2018$454,000
+1581.5%
95,780
+770.7%
0.00%
Q2 2017$27,000
-6.9%
11,000
-45.2%
0.00%
Q1 2016$29,000
-3.3%
20,086
+9.9%
0.00%
Q4 2015$30,000
-82.2%
18,279
-74.7%
0.00%
Q3 2015$169,000
-6.6%
72,145
+9.0%
0.00%
Q2 2015$181,000
+187.3%
66,196
+251.6%
0.00%
Q1 2015$63,000
-25.0%
18,826
-22.6%
0.00%
Q4 2014$84,000
+10.5%
24,322
+60.4%
0.00%
Q3 2014$76,000
-96.8%
15,165
-90.4%
0.00%
-100.0%
Q1 2014$2,411,000157,4750.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders